Skip to main content

Your search for “Gastroenterology” returned 114 results

UC San Diego Named Among World’s Top 20 Universities by U.S. News & World Report

October 27, 2022

The University of California San Diego has been ranked among the top 20 universities in the world, according to U.S. News & World Report’s 2022-2023 Best Global Universities.

Gastrointestinal Hormone Measurably Improved Symptoms of Non-Alcoholic Fatty Liver Disease

March 8, 2018

Through a randomized, double-blind, placebo-controlled phase II clinical trial, researchers at University of California San Diego School of Medicine report that small doses of NGM282, a non-tumorigenic variant of an endocrine gastrointestinal hormone, can significantly and rapidly decrease liver fat content in patients with non-alcoholic fatty liver disease (NAFLD) and…

Study Finds Psoriasis Drug Significantly Effective in Treating Crohn’s Disease

November 16, 2016

Researchers at University of California San Diego School of Medicine have shown that ustekinumab, a human antibody used to treat arthritis, significantly induces response and remission in patients with moderate to severe Crohn’s disease. Results of the clinical trial will appear in the November 16 issue of the New England…

UC San Diego’s ‘Proof-of-Concept’ Awards Move Campus Health Innovations to Market

July 13, 2018

Nine teams of UC San Diego students, faculty and other researchers who have developed novel innovations that could improve various aspects of health care, have been awarded proof-of-concept awards designed to help bring their campus inventions to commercial use.

UC San Diego Health Ranks #1 by U.S. News & World Report

July 20, 2015

Once again, UC San Diego Health and its hospitals are ranked #1 in San Diego, and recognized among the best in the nation, by U.S. News & World Report for 2015-16. The annual U.S. News “Best Hospitals” rankings distinguish hospitals that excel in treating the most challenging health conditions.

Study: Potential New Treatment Identified for Liver Disease

June 26, 2023

Researchers with UC San Diego School of Medicine identified a potential new drug that improved liver fibrosis in patients with NASH by 27%.

Two Studies Identify Potential New Drug for Crohn’s Disease and Ulcerative Colitis

August 21, 2013

Vedolizumab, a new intravenous antibody medication, has shown positive results for treating both Crohn’s disease and ulcerative colitis, according to researchers at the University of California San Diego, School of Medicine. The findings, published in two papers, will appear in the August 22 issue of the New England Journal of…

Study: First-Degree Relatives of Patients with NAFLD at Risk of Liver Disease

November 1, 2022

New study identifies that first-degree relatives of patients with nonalcoholic fatty liver disease with advanced fibrosis (scarring of the liver) are at a 15% risk of developing the condition.

Alcohol Also Damages the Liver by Allowing Bacteria to Infiltrate

February 10, 2016

Alcohol itself can directly damage liver cells. Now researchers at University of California, San Diego School of Medicine report evidence that alcohol is also harmful to the liver for a second reason — it allows gut bacteria to migrate to the liver, promoting alcohol-induced liver disease. The study, conducted in…

A New Protein Target for Controlling Diabetes

April 11, 2013

Researchers at the University of California, San Diego School of Medicine have identified a previously unknown biological mechanism involved in the regulation of pancreatic islet beta cells, whose role is to produce and release insulin. The discovery suggests a new therapeutic target for treating dysfunctional beta cells and type 2…

Category navigation with Social links